Alzheimer's Disease (AD) is the most common neurodegenerative disease. Its first stage, namely prodromal or Mild Cognitive Impairment (MCI), is characterized by slightly structural changes in the subcortical structures of the temporal lobe. Brain Magnetic Resonance (MR) is the most utilized neu-roimaging modality for the diagnosis of AD. Although an early therapeutic intervention during the initial stages of AD appears to have a positive impact on the progression of symptoms, its accurate diagnosis is still very difficult. Deep Learning (DL)-based decision-support systems hold great potential in generalizing even under subtle anatomical changes of the brain, like the ones caused by AD at its onset. To our knowledge, we were the first to develop a Convolutional Long Short-Term Memory (ConvLSTM)-based decision-support system and an improved version of it for the automatic diagnosis of AD from 3D brain MR. The research presented in this paper aims to extend their applicability to MCI for effectiveness verification through the development of CLAUDIA, a new on-cloud decision-support system for the automatic diagnosis of Alzheimer's prodromal stage and disease from 3D brain MR. To this aim, we selected 438 unenhanced scans from the ADNI-1 dataset, preprocessed them, and injected the preprocessed scans to the ConvLSTM-based neural network for automatic feature extraction and binary/multiclass classification. On test data, CLAUDIA achieved very encouraging results that highlight the superiority of the multiclass classifier in comparison to the two binary classifiers. On the basis of the achieved outcomes, we demonstrated that CLAUDIA, being the first to extend the applicability of a ConvLSTM-based neural network to MCI for effectiveness verification, represents a promising scan-, DL-based decision-support system for the automatic diagnosis of Alzheimer's prodromal stage and disease from 3D brain MR. Moreover, its cloud thus machine-independent nature ensures a full reproducibility of the implementation while guaranteeing cost saving and sustainability.

CLAUDIA: Cloud-based Automatic Diagnosis of Alzheimer's Prodromal Stage and Disease from 3D Brain Magnetic Resonance / Tomassini, S.; Sbrollini, A.; Morettini, M.; Dragoni, A. F.; Burattini, L.. - ELETTRONICO. - 2023:(2023), pp. 450-455. (Intervento presentato al convegno 36th IEEE International Symposium on Computer-Based Medical Systems, CBMS 2023 tenutosi a L'Aquila, Italia nel 22-24 Giugno, 2023) [10.1109/CBMS58004.2023.00261].

CLAUDIA: Cloud-based Automatic Diagnosis of Alzheimer's Prodromal Stage and Disease from 3D Brain Magnetic Resonance

Tomassini S.;Sbrollini A.;Morettini M.;Dragoni A. F.;Burattini L.
2023-01-01

Abstract

Alzheimer's Disease (AD) is the most common neurodegenerative disease. Its first stage, namely prodromal or Mild Cognitive Impairment (MCI), is characterized by slightly structural changes in the subcortical structures of the temporal lobe. Brain Magnetic Resonance (MR) is the most utilized neu-roimaging modality for the diagnosis of AD. Although an early therapeutic intervention during the initial stages of AD appears to have a positive impact on the progression of symptoms, its accurate diagnosis is still very difficult. Deep Learning (DL)-based decision-support systems hold great potential in generalizing even under subtle anatomical changes of the brain, like the ones caused by AD at its onset. To our knowledge, we were the first to develop a Convolutional Long Short-Term Memory (ConvLSTM)-based decision-support system and an improved version of it for the automatic diagnosis of AD from 3D brain MR. The research presented in this paper aims to extend their applicability to MCI for effectiveness verification through the development of CLAUDIA, a new on-cloud decision-support system for the automatic diagnosis of Alzheimer's prodromal stage and disease from 3D brain MR. To this aim, we selected 438 unenhanced scans from the ADNI-1 dataset, preprocessed them, and injected the preprocessed scans to the ConvLSTM-based neural network for automatic feature extraction and binary/multiclass classification. On test data, CLAUDIA achieved very encouraging results that highlight the superiority of the multiclass classifier in comparison to the two binary classifiers. On the basis of the achieved outcomes, we demonstrated that CLAUDIA, being the first to extend the applicability of a ConvLSTM-based neural network to MCI for effectiveness verification, represents a promising scan-, DL-based decision-support system for the automatic diagnosis of Alzheimer's prodromal stage and disease from 3D brain MR. Moreover, its cloud thus machine-independent nature ensures a full reproducibility of the implementation while guaranteeing cost saving and sustainability.
2023
979-8-3503-1224-9
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11566/320312
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact